207 related articles for article (PubMed ID: 25754495)
1. The discovery of potent agonists for GPR88, an orphan GPCR, for the potential treatment of CNS disorders.
Bi Y; Dzierba CD; Fink C; Garcia Y; Green M; Han J; Kwon S; Kumi G; Liang Z; Liu Y; Qiao Y; Zhang Y; Zipp G; Burford N; Ferrante M; Bertekap R; Lewis M; Cacace A; Westphal RS; Kimball D; Bronson JJ; Macor JE
Bioorg Med Chem Lett; 2015 Apr; 25(7):1443-7. PubMed ID: 25754495
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and evaluation of phenylglycinols and phenyl amines as agonists of GPR88.
Dzierba CD; Bi Y; Dasgupta B; Hartz RA; Ahuja V; Cianchetta G; Kumi G; Dong L; Aleem S; Fink C; Garcia Y; Green M; Han J; Kwon S; Qiao Y; Wang J; Zhang Y; Liu Y; Zipp G; Liang Z; Burford N; Ferrante M; Bertekap R; Lewis M; Cacace A; Grace J; Wilson A; Nouraldeen A; Westphal R; Kimball D; Carson K; Bronson JJ; Macor JE
Bioorg Med Chem Lett; 2015 Apr; 25(7):1448-52. PubMed ID: 25690789
[TBL] [Abstract][Full Text] [Related]
3. Discovery of S-adenosyl-L-homocysteine hydrolase inhibitors based on non-adenosine analogs.
Nakao A; Suzuki H; Ueno H; Iwasaki H; Setsuta T
Bioorg Med Chem Lett; 2014 Sep; 24(17):4336-40. PubMed ID: 25022879
[TBL] [Abstract][Full Text] [Related]
4. Orphan receptor GPR88 as a potential therapeutic target for CNS disorders - an
Garisetti V; Dhanabalan AK; Dasararaju G
J Biomol Struct Dyn; 2024 Jun; 42(9):4745-4758. PubMed ID: 37306437
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and pharmacological evaluation of 4-hydroxyphenylglycine and 4-hydroxyphenylglycinol derivatives as GPR88 agonists.
Jin C; Decker AM; Langston TL
Bioorg Med Chem; 2017 Jan; 25(2):805-812. PubMed ID: 27956039
[TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis, and Structure-Activity Relationship Studies of Novel GPR88 Agonists (4-Substituted-phenyl)acetamides Based on the Reversed Amide Scaffold.
Rahman MT; Guan D; Chaminda Lakmal HH; Decker AM; Imler GH; Kerr AT; Harris DL; Jin C
ACS Chem Neurosci; 2024 Jan; 15(1):169-192. PubMed ID: 38086012
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and in vitro evaluation of novel uni- and bivalent ligands for the cannabinoid receptor type 1 with variation of spacer length and structure.
Huang G; Pemp D; Stadtmüller P; Nimczick M; Heilmann J; Decker M
Bioorg Med Chem Lett; 2014 Sep; 24(17):4209-14. PubMed ID: 25096297
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a high-throughput calcium mobilization assay for the orphan receptor GPR88.
Decker AM; Gay EA; Mathews KM; Rosa TC; Langston TL; Maitra R; Jin C
J Biomed Sci; 2017 Mar; 24(1):23. PubMed ID: 28347302
[TBL] [Abstract][Full Text] [Related]
9. Orphan Receptor GPR88 as an Emerging Neurotherapeutic Target.
Ye N; Li B; Mao Q; Wold EA; Tian S; Allen JA; Zhou J
ACS Chem Neurosci; 2019 Jan; 10(1):190-200. PubMed ID: 30540906
[TBL] [Abstract][Full Text] [Related]
10. Discovery of 5-phenoxy-1,3-dimethyl-1H-pyrazole-4-carboxamides as potent agonists of TGR5 via sequential combinatorial libraries.
Londregan AT; Piotrowski DW; Futatsugi K; Warmus JS; Boehm M; Carpino PA; Chin JE; Janssen AM; Roush NS; Buxton J; Hinchey T
Bioorg Med Chem Lett; 2013 Mar; 23(5):1407-11. PubMed ID: 23337601
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, pharmacological characterization, and structure-activity relationship studies of small molecular agonists for the orphan GPR88 receptor.
Jin C; Decker AM; Huang XP; Gilmour BP; Blough BE; Roth BL; Hu Y; Gill JB; Zhang XP
ACS Chem Neurosci; 2014 Jul; 5(7):576-87. PubMed ID: 24793972
[TBL] [Abstract][Full Text] [Related]
12. Combinatorial synthesis of 3-(amidoalkyl) and 3-(aminoalkyl)-2-arylindole derivatives: discovery of potent ligands for a variety of G-protein coupled receptors.
Willoughby CA; Hutchins SM; Rosauer KG; Dhar MJ; Chapman KT; Chicchi GG; Sadowski S; Weinberg DH; Patel S; Malkowitz L; Di Salvo J; Pacholok SG; Cheng K
Bioorg Med Chem Lett; 2002 Jan; 12(1):93-6. PubMed ID: 11738581
[TBL] [Abstract][Full Text] [Related]
13. Orphan G protein-coupled receptors: The role in CNS disorders.
Alavi MS; Shamsizadeh A; Azhdari-Zarmehri H; Roohbakhsh A
Biomed Pharmacother; 2018 Feb; 98():222-232. PubMed ID: 29268243
[TBL] [Abstract][Full Text] [Related]
14. Discovery of aminoheterocycles as potent and brain penetrant prolylcarboxypeptidase inhibitors.
Wu Z; Yang C; Graham TH; Verras A; Chabin RM; Xu S; Tong X; Xie D; Lassman ME; Bhatt UR; Garcia-Calvo MM; Shen Z; Chen Q; Bleasby K; Sinharoy R; Hale JJ; Tata JR; Pinto S; Colletti SL; Shen DM
Bioorg Med Chem Lett; 2012 Feb; 22(4):1727-30. PubMed ID: 22290078
[TBL] [Abstract][Full Text] [Related]
15. Discovery of biological evaluation of pyrazole/imidazole amides as mGlu5 receptor negative allosteric modulators.
Chae E; Shin YJ; Ryu EJ; Ji MK; Ryune Cho N; Lee KH; Jeong HJ; Kim SJ; Choi Y; Seok Oh K; Park CE; Soo Yoon Y
Bioorg Med Chem Lett; 2013 Apr; 23(7):2134-9. PubMed ID: 23434029
[TBL] [Abstract][Full Text] [Related]
16. Discovery and development of a novel class of phenoxyacetyl amides as highly potent TRPM8 agonists for use as cooling agents.
Noncovich A; Priest C; Ung J; Patron AP; Servant G; Brust P; Servant N; Faber N; Liu H; Gonsalves NS; Ditschun TL
Bioorg Med Chem Lett; 2017 Aug; 27(16):3931-3938. PubMed ID: 28662813
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Amide Bioisosteres Leading to 1,2,3-Triazole Containing Compounds as GPR88 Agonists: Design, Synthesis, and Structure-Activity Relationship Studies.
Rahman MT; Decker AM; Laudermilk L; Maitra R; Ma W; Ben Hamida S; Darcq E; Kieffer BL; Jin C
J Med Chem; 2021 Aug; 64(16):12397-12413. PubMed ID: 34387471
[TBL] [Abstract][Full Text] [Related]
18. Novel, potent small-molecule inhibitors of the molecular chaperone Hsp90 discovered through structure-based design.
Dymock BW; Barril X; Brough PA; Cansfield JE; Massey A; McDonald E; Hubbard RE; Surgenor A; Roughley SD; Webb P; Workman P; Wright L; Drysdale MJ
J Med Chem; 2005 Jun; 48(13):4212-5. PubMed ID: 15974572
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of aryl N-methoxyamide derivatives as GPR119 agonists.
Jang YK; Lee KM; Jung KY; Kang SK; Pagire SH; Lee JM; Pagire HS; Kim KR; Bae MA; Lee H; Rhee SD; Ahn JH
Bioorg Med Chem Lett; 2017 Aug; 27(16):3909-3914. PubMed ID: 28666737
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Structure-Activity Relationships of N-Dihydrocoptisine-8-ylidene Aromatic Amines and N-Dihydrocoptisine-8-ylidene Aliphatic Amides as Antiulcerative Colitis Agents Targeting XBP1.
Xie M; Zhang HJ; Deng AJ; Wu LQ; Zhang ZH; Li ZH; Wang WJ; Qin HL
J Nat Prod; 2016 Apr; 79(4):775-83. PubMed ID: 26981782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
